Premier is first company allowed access to CMS data

The Centers for Medicare & Medicaid Services (CMS) has granted Premier access to its Virtual Research Data Center (VRDC) to develop innovations that drive healthcare transformation.

Premier is the first organization to conduct Innovator Research using the VRDC, a virtual research environment, and will derive insights from privacy-protected Medicare data that are expected to result in the development of solutions to benefit patients and the healthcare system overall.

“Being approved to use the CMS VRDC signifies our leadership in creating innovative solutions to improve patient care,” said Wes Champion, senior vice president of Premier Performance Partners. “Access to the VRDC will allow Premier to calculate timelier performance measures than currently available and identify additional opportunity areas to help move healthcare performance improvement further, faster.”

CMS began accepting requests from innovators and entrepreneurs in September 2015 to conduct approved research that will ultimately improve care and provide better tools to benefit healthcare consumers. Previously, commercial entities were denied access to CMS data for these purposes.

As part of its approved research, Premier Insights, one of Premier’s research and analytics divisions, will seek to use additional data to identify interventions that drive quality improvement and cost containment. In doing so, Premier will analyze episodes of care across the continuum to determine clinical best practices that provide the greatest improvements in care and reductions in costs. Premier members will receive reports containing these benchmarks and findings to integrate into their care transformation efforts. Premier will then seek to determine whether these reports in addition to its other collaborative methodologies enable its members to outperform others.

Premier will publish its key findings to assist other providers and form the basis for future measures and performance improvement solutions offered through Premier’s quality cycle management collaboratives, data analytics and consulting services.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.